Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir
Clinical trial NCT00120393 · COMPLETED
Trial details
- NCT number
- NCT00120393
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-05-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.